REXLUCI Trademark

Trademark Overview

On Wednesday, September 3, 2014, a trademark application was filed for REXLUCI with the United States Patent and Trademark Office. The USPTO has given the REXLUCI trademark a serial number of 86384364. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 13, 2018. This trademark is owned by H. Lundbeck A/S. The REXLUCI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment and prevention of brain and central nervous diseases and disorders; vaccines; pharmaceutical preparation and substances for the prevention and treatment of disorders and diseases in, generated from or affecting the brain and the central nervous system; pharmaceutical preparations and substances acting on the brain and central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, depression, mood disorder, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson disease and disorder, schizophrenia, bipolar disease and disorder, oncology, pain, alcoholism and dependency; medical diagnostic preparations, substances, reagents and agents
rexluci

General Information

Serial Number86384364
Word MarkREXLUCI
Filing DateWednesday, September 3, 2014
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 13, 2018
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 12, 2015

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment and prevention of brain and central nervous diseases and disorders; vaccines; pharmaceutical preparation and substances for the prevention and treatment of disorders and diseases in, generated from or affecting the brain and the central nervous system; pharmaceutical preparations and substances acting on the brain and central nervous system; central nervous system stimulants; pharmaceutical preparations and substances for the prevention and treatment of psychiatric and neurological diseases and disorders; pharmaceutical preparations and substances for the prevention and treatment of Alzheimer's disease and disorder, depression, mood disorder, psychosis, anxiety, epilepsy, sclerosis, porphyria, Huntington's disease and disorder, insomnia, Parkinson disease and disorder, schizophrenia, bipolar disease and disorder, oncology, pain, alcoholism and dependency; medical diagnostic preparations, substances, reagents and agents

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, September 13, 2014
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameH. Lundbeck A/S
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressValby 2500
DK
Party NameH. Lundbeck A/S
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressValby 2500
DK

Trademark Events

Event DateEvent Description
Monday, August 13, 2018ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, August 13, 2018ABANDONMENT - NO USE STATEMENT FILED
Tuesday, December 12, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, December 9, 2017EXTENSION 5 GRANTED
Thursday, December 7, 2017EXTENSION 5 FILED
Thursday, December 7, 2017TEAS EXTENSION RECEIVED
Friday, June 9, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 7, 2017EXTENSION 4 GRANTED
Wednesday, June 7, 2017EXTENSION 4 FILED
Wednesday, June 7, 2017TEAS EXTENSION RECEIVED
Wednesday, June 7, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, January 5, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 3, 2017EXTENSION 3 GRANTED
Tuesday, January 3, 2017EXTENSION 3 FILED
Tuesday, January 3, 2017TEAS EXTENSION RECEIVED
Friday, July 8, 2016NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, July 7, 2016EXTENSION 2 GRANTED
Wednesday, June 1, 2016EXTENSION 2 FILED
Tuesday, July 5, 2016CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, June 1, 2016TEAS EXTENSION RECEIVED
Thursday, December 3, 2015NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, December 1, 2015EXTENSION 1 GRANTED
Tuesday, December 1, 2015EXTENSION 1 FILED
Tuesday, December 1, 2015TEAS EXTENSION RECEIVED
Tuesday, July 7, 2015NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 12, 2015OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 12, 2015PUBLISHED FOR OPPOSITION
Wednesday, April 22, 2015NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Friday, April 3, 2015LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, March 31, 2015APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, February 16, 2015TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 16, 2015CORRESPONDENCE RECEIVED IN LAW OFFICE
Friday, February 6, 2015ASSIGNED TO LIE
Thursday, January 29, 2015TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, October 9, 2014NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, October 9, 2014NON-FINAL ACTION E-MAILED
Thursday, October 9, 2014NON-FINAL ACTION WRITTEN
Tuesday, September 30, 2014ASSIGNED TO EXAMINER
Saturday, September 13, 2014NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Saturday, September 6, 2014NEW APPLICATION ENTERED IN TRAM

Related Keywords

rexluci substances pharmaceutical disorder preparations nervous disease central treatment prevention brain